Etihad Airways starts IATA pass trial on flights from Abu Dhabi to North America

Mohammad Al Bulooki, Chief Operating Officer, Etihad Aviation Group, said: "With the dynamically changing health requirements for travel, Etihad believes that a digital health passport solution will provide additional clarity and ease for travellers

  
Etihad Airways starts IATA pass trial on flights from Abu Dhabi to North America

Abu Dhabi – Guests travelling with Etihad Airways, the national carrier of the United Arab Emirates, from now until 31 May from Abu Dhabi to Chicago, New York, Washington and Toronto, will be the first to trial the IATA Travel Pass app to easily manage their travel health credentials.

Mohammad Al Bulooki, Chief Operating Officer, Etihad Aviation Group, said: “With the dynamically changing health requirements for travel, Etihad believes that a digital health passport solution will provide additional clarity and ease for travellers. Etihad has partnered with IATA so that together, a globally unified approach to a travel pass can be simplified to make travel easier once governments decide what regulations are required to cross borders in either direction.”

To participate in the trial, guests simply download the IATA Travel Pass app from the Apple App Store and book an appointment with Life Diagnostics at Sultan Bin Zayed the First Street or BioGenix Labs at Masdar City. At the clinic, guests inform reception they are participating in the IATA Travel Pass trial and should be ready to show their passport and mobile device with the IATA Travel Pass app downloaded. Once the test result is ready, travellers will be able to view it on both the IATA Travel Pass app and through the testing clinic’s own digital platform.

“Etihad Airways trial of IATA Travel Pass will help build confidence among governments and travellers that digital health apps can safely, securely and conveniently help restart aviation. The app gives travellers a one-stop-shop to help them comply with the new rules for travel, and for governments complete assurance in the identity of the passenger and the authenticity of the travel credentials being presented,” said Nick Careen, IATA Senior Vice President for Airport, Passenger, Cargo and Security.

The IATA Travel Pass will enable Etihad’s guests to create a ‘digital passport’ to receive Covid test results and verify they are eligible to undertake their journey. Importantly, IATA Travel Pass will keep passengers in control of their data and facilitate the sharing of their test with airlines and authorities for travel. It will also make it convenient for passengers to manage travel documentation throughout their journey.

Guests participating in the IATA Travel Pass pilot will benefit from priority queue access at Life Diagnostics and Biogenix Labs for their PCR test, faster check-in at the airport and a free 90mb Wi-Fi voucher to use in-flight. Guest who do not wish to participate in the trial can continue to follow the existing method of sharing PCR test results with Etihad by presenting a printed copy of their results at check in.

- Ends-

For further details:
Duty Media Officer
Etihad Airways
Email: dutymediaofficer@etihad.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases